Short answer
Danaher Corporation (DHR) filed its Q1 2025 10-Q quarterly report on Apr 22, 2025 for the quarter ended Mar 28, 2025. Quarterly revenue was $5.7B (down 0.9% year over year) with net income of $954M.
Q1 2025 key financials · XBRL
- Revenue
- $5.7B
- −0.9% YoY
- Net income
- $954M
- −12.3% YoY
- Operating margin
- 22.2%
- Gross margin
- 61.2%
- EPS (diluted)
- $1.32
- −9.0% YoY
Source: XBRL data from the Danaher Corporation (DHR) Q1 2025 10-Q on SEC EDGAR. USD.
Danaher Corporation Q1 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Newly added trade tariff risk triggered by recent U.S. and retaliatory tariffs with China, increasing supply costs and potentially reducing product demand
- Materially updated supply chain risk due to ongoing tariffs causing potential product availability issues and operational disruptions
- Regulatory risk from evolving national policies promoting reshoring and local production, including China’s medical device development incentives
- Market risk from potential demand reduction due to increased customer costs from surcharges and price increases related to tariffs
- Financial risk from margin pressure when increased costs cannot be fully or timely recovered due to tariffs and inflation effects
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Danaher Corporation quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.